- Home
- TRVG vs ABSI Comparison
TRVG vs ABSI Comparison
Compare TRVG & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVG
- ABSI
- Stock Information
- Founded
- TRVG 2005
- ABSI 2011
- Country
- TRVG Germany
- ABSI United States
- Employees
- TRVG N/A
- ABSI N/A
- Industry
- TRVG EDP Services
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- TRVG Technology
- ABSI Health Care
- Exchange
- TRVG Nasdaq
- ABSI Nasdaq
- Market Cap
- TRVG 306.5M
- ABSI 318.2M
- IPO Year
- TRVG N/A
- ABSI 2021
- Fundamental
- Price
- TRVG $4.31
- ABSI $3.23
- Analyst Decision
- TRVG Buy
- ABSI Strong Buy
- Analyst Count
- TRVG 4
- ABSI 7
- Target Price
- TRVG $2.55
- ABSI $8.57
- AVG Volume (30 Days)
- TRVG 114.9K
- ABSI 5.0M
- Earning Date
- TRVG 04-29-2025
- ABSI 03-18-2025
- Dividend Yield
- TRVG N/A
- ABSI N/A
- EPS Growth
- TRVG N/A
- ABSI N/A
- EPS
- TRVG N/A
- ABSI N/A
- Revenue
- TRVG $477,118,749.00
- ABSI $4,207,000.00
- Revenue This Year
- TRVG $9.85
- ABSI $7.92
- Revenue Next Year
- TRVG $6.77
- ABSI $162.34
- P/E Ratio
- TRVG N/A
- ABSI N/A
- Revenue Growth
- TRVG N/A
- ABSI N/A
- 52 Week Low
- TRVG $1.60
- ABSI $2.45
- 52 Week High
- TRVG $5.03
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- TRVG 56.05
- ABSI 41.02
- Support Level
- TRVG $3.90
- ABSI $2.90
- Resistance Level
- TRVG $4.29
- ABSI $3.26
- Average True Range (ATR)
- TRVG 0.36
- ABSI 0.27
- MACD
- TRVG -0.07
- ABSI -0.09
- Stochastic Oscillator
- TRVG 38.57
- ABSI 21.61
About TRVG trivago N.V.
trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.